Biomea Fusion BMEA shares closed up on Friday as the company is presenting positive data from its Phase II COVALENT-111 study ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

In particular, it’s been pretty common for a long time that people with type 1 diabetes take drugs that are only approved and labeled for type 2 diabetes. This is especially true for Metformin, the ...

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 diabetes compared to other diabetes medications.

In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and inflammation, potentially offering a powerful new way to protect the heart ...

Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

A comprehensive Lancet review synthesizes evidence from major clinical trials showing that GLP-1 receptor agonists and ...

Add Yahoo as a preferred source to see more of our stories on Google. People with type 2 diabetes and obesity may live longer, healthier lives if they undergo metabolic surgery rather than relying ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition. For ...

First new drug in 30 years to slow kidney disease in type 1 diabetes ...